277136
Fosaprepitant was developed by Merck & Co. and was approved by the United States Food and Drug Administration ( FDA ) on January 25 , 2008 and by the European Medicines Agency ( EMA ) on January 11 of the same year .
 organization: Merck & Co.; location: United States Food and Drug Administration; organization: European Medicines Agency
Given options, please tell me the categories of all the listed entity words.Output format is "type1: word1; type2: word2". 
Option: location, person, organization 
Text: {0} 
 Entities: Merck & Co., United States Food and Drug Administration, European Medicines Agency 
Answer:
 organization: Merck & Co.; location: United States Food and Drug Administration; organization: European Medicines Agency